As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2026 at 4:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.

The company has informed that the Board of Directors of the Company, at its 232nd Board Meeting held on Monday, 28 September 2026 at 4:00 pm through Hybrid system, has approved an additional equity investment of BDT 600 million in ACI CO-RO BANGLADESH LTD., an existing Joint Venture of the Company. The said investment will be made subject to the approval of the concerned regulatory authority.

The company has informed that the Board of Directors of the Company, at its 232nd Board meeting held on Monday, 28 September 2026 at 4:00 pm through Hybrid system, approved the formation of a joint-venture company under the title of "ACI-ICHINEN BANGLADESH LTD." having an authorized capital of BDT 500,000,000 (Five Hundred Million) and a paid up capital of BDT 150,000,000 (One Hundred Fifty Million) wherein Advanced Chemical Industries PLC shall hold 60% shares, subject to the approval of the concerned authority.

The company has informed that the Board of Directors of the Company in its meeting held on 28 July 2026 approved the formation of a new subsidiary company under the title of "ACI Global Scientific Standards Limited" having an authorized capital of BDT 50 (Fifty) Crore and a paid up capital of BDT 3 (Three) Crore wherein Advanced Chemical Industries PLC shall hold 85% shares, subject to the approval of the concerned authorities.

The Board of Directors of the Company, at its 230th Board meeting held on 14 July 2026 has approved an investment of BDT 700 Crore in ACI Logistics Limited, a subsidiary of the Company. The investment will be made through the subscription of 7,000,000 (Seven Million) Convertible Preference Shares of BDT 1,000/- (BDT One Thousand) each, to be issued by ACI Logistics Limited. The investment will be made on or before 15 October 2026, subject to the approval of the concerned authorities.

(Q3 Un-audited): Consolidated EPS was Tk. (4.91) for January-March 2026 as against Tk. (1.12) for January-March 2025; Consolidated EPS was Tk. (4.18) for July 2025-March 2026 as against Tk. (9.11) for July 2024-March 2025. Consolidated NOCFPS was Tk. (68.02) for July 2025-March 2026 as against Tk. (83.14) for July 2024-March 2025. Consolidated NAV per share was Tk. 85.78 as on March 31, 2026 and Tk. 91.64 as on June 30, 2025. (cont.1) (Continuation news of ACI): Reasons for significant deviations: During the nine months ended on 31 March 2026, the Group achieved a 15% revenue growth which was contributed by a number of businesses as demonstrated in Consolidated Operating Segments in Annexure A. During the period, increase in gross profit exceeded the increase in operating expenses driven by growth in key segments. (cont.2) (Continuation news of ACI): On the other hand, cost of borrowing increased due to additional funding for working capital and strategic investments for supporting business growth. Overall, the consolidated EPS was Taka (4.18) during the period against Taka (9.11) of SPLY. NOCFPS during the period was Taka (68.02) against Taka (83.14) as a result of the movement in the working capital.

The company has informed that the Board of Directors of the Company in its meeting held on 29 April 2026 approved the formation of a joint-venture company under the title of "Deli ACI Bangladesh Limited" having an authorized capital of BDT 100 (One Hundred) Crore and a paid up capital of BDT 27 (Twenty-Seven) Crore wherein Advanced Chemical Industries PLC shall hold 50% shares, subject to the approval of the concerned authority.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

Dr. Arif Dowla, Managing Director of the company, has further informed that he has completed his buying of 302,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 09.04.2026.

Dr. Arif Dowla, Managing Director of the company, has expressed his intention to buy 302,000 shares of the company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within April 30, 2026 pursuant to the Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.